Clinical Trial Update: Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 dose-finding study of M516102 for pruritus in patients with Atopic Dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• M516102

Snippet

Sponsor: Maruho Co., Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED